CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects
- Author
- SAKAI, Toshiyuki1 ; AOYAMA, Nobuo1 2 ; KASUGA, Masato1 ; OKUMURA, Katsuhiko3 ; KITA, Tomoko3 ; SAKAEDA, Toshiyuki3 ; NISHIGUCHI, Kohshi3 ; NISHITORA, Yukari3 ; HOHDA, Takashi3 ; SIRASAKA, Daisuke1 ; TAMURA, Takao1 ; TANIGAWARA, Yusuke3 4
[1] Second Department of Internal Medicine, School of Medicine Kobe University, Chuo-ku, Kobe 650-0017, Japan
[2] Department of Endoscopy, School of Medicine, Kobe University, Chuo-ku, Kobe 650-0017, Japan
[3] Department of Hospital Pharmacy, School of Medicine, Kobe University, Chuo-ku, Kobe 650-0017, Japan
[4] Department of Hospital Pharmacy, School of Medicine, Keio University, Shinjuku-ku, Tokyo 160-8582, Japan - Source
Pharmaceutical research. 2001, Vol 18, Num 6, pp 721-727 ; ref : 34 ref
- CODEN
- PHREEB
- ISSN
- 0724-8741
- Scientific domain
- Pharmacology drugs
- Publisher
- Springer, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Absorption Antiulcéreux Benzimidazole dérivé Cytochrome P450 Dose unique Génotype Homme Inhibiteur pompe proton Lansoprazole Métabolisme Normal Oméprazole Pharmacocinétique Plasma sanguin Rabéprazole Randomisation Voie orale Gène CYP2C19
- Keyword (en)
- Absorption Antiulcer agent Benzimidazole derivatives Cytochrome P450 Single dose Genotype Human Proton pump inhibitor Lansoprazole Metabolism Normal Omeprazole Pharmacokinetics Blood plasma Rabeprazole Randomization Oral administration
- Keyword (es)
- Absorción Antiulceroso Benzimidazol derivado Citocromo P450 Dosis única Genotipo Hombre Inhibidor bomba protón Lansoprazol Metabolismo Normal Omeprazol Farmacocinética Plasma sanguíneo Rabeprazol Aleatorización Vía oral
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02H Digestive system
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 1073734
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1023/A:1011035007591 
https://dx.doi.org/10.1023/A:1011035007591
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1023\/A:1011035007591\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Pharmaceutical research\";s:9:\"\u0000*\u0000stitle\";s:10:\"Pharm. res\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:2:\"18\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"721\";s:8:\"\u0000*\u0000epage\";s:3:\"727\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0724-8741\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"SAKAI\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Toshiyuki\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:13:\"AOYAMA, Nobuo\";i:1;s:14:\"KASUGA, Masato\";i:2;s:18:\"OKUMURA, Katsuhiko\";i:3;s:12:\"KITA, Tomoko\";i:4;s:18:\"SAKAEDA, Toshiyuki\";i:5;s:18:\"NISHIGUCHI, Kohshi\";i:6;s:17:\"NISHITORA, Yukari\";i:7;s:14:\"HOHDA, Takashi\";i:8;s:17:\"SIRASAKA, Daisuke\";i:9;s:13:\"TAMURA, Takao\";i:10;s:18:\"TANIGAWARA, Yusuke\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"PHREEB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:89:\"CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1023\/A:1011035007591\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Pharmaceutical research\";s:9:\"\u0000*\u0000stitle\";s:10:\"Pharm. res\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:2:\"18\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"721\";s:8:\"\u0000*\u0000epage\";s:3:\"727\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0724-8741\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"SAKAI\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Toshiyuki\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:13:\"AOYAMA, Nobuo\";i:1;s:14:\"KASUGA, Masato\";i:2;s:18:\"OKUMURA, Katsuhiko\";i:3;s:12:\"KITA, Tomoko\";i:4;s:18:\"SAKAEDA, Toshiyuki\";i:5;s:18:\"NISHIGUCHI, Kohshi\";i:6;s:17:\"NISHITORA, Yukari\";i:7;s:14:\"HOHDA, Takashi\";i:8;s:17:\"SIRASAKA, Daisuke\";i:9;s:13:\"TAMURA, Takao\";i:10;s:18:\"TANIGAWARA, Yusuke\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"PHREEB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:89:\"CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:23:\"10.1023\/A:1011035007591\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1023\/A:1011035007591\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Pharmaceutical research\";s:9:\"\u0000*\u0000stitle\";s:10:\"Pharm. res\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:2:\"18\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"721\";s:8:\"\u0000*\u0000epage\";s:3:\"727\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0724-8741\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"SAKAI\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Toshiyuki\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:13:\"AOYAMA, Nobuo\";i:1;s:14:\"KASUGA, Masato\";i:2;s:18:\"OKUMURA, Katsuhiko\";i:3;s:12:\"KITA, Tomoko\";i:4;s:18:\"SAKAEDA, Toshiyuki\";i:5;s:18:\"NISHIGUCHI, Kohshi\";i:6;s:17:\"NISHITORA, Yukari\";i:7;s:14:\"HOHDA, Takashi\";i:8;s:17:\"SIRASAKA, Daisuke\";i:9;s:13:\"TAMURA, Takao\";i:10;s:18:\"TANIGAWARA, Yusuke\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"PHREEB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:89:\"CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1023\/A:1011035007591\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:89:\"CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Pharmaceutical research\";s:9:\"\u0000*\u0000stitle\";s:10:\"Pharm. res\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:2:\"18\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:3:\"721\";s:8:\"\u0000*\u0000epage\";s:3:\"727\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0724-8741\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"SAKAI\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Toshiyuki\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:13:\"AOYAMA, Nobuo\";i:1;s:14:\"KASUGA, Masato\";i:2;s:18:\"OKUMURA, Katsuhiko\";i:3;s:12:\"KITA, Tomoko\";i:4;s:18:\"SAKAEDA, Toshiyuki\";i:5;s:18:\"NISHIGUCHI, Kohshi\";i:6;s:17:\"NISHITORA, Yukari\";i:7;s:14:\"HOHDA, Takashi\";i:8;s:17:\"SIRASAKA, Daisuke\";i:9;s:13:\"TAMURA, Takao\";i:10;s:18:\"TANIGAWARA, Yusuke\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"PHREEB\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:89:\"CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Springer\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
